West Pharmaceutical Services EBIT 2010-2024 | WST

West Pharmaceutical Services annual and quarterly EBIT history from 2010 to 2024. EBIT can be defined as earnings before interest and taxes.
  • West Pharmaceutical Services EBIT for the quarter ending June 30, 2024 was $0.126B, a 30.85% decline year-over-year.
  • West Pharmaceutical Services EBIT for the twelve months ending June 30, 2024 was $0.587B, a 10.17% decline year-over-year.
  • West Pharmaceutical Services 2023 annual EBIT was $0.676B, a 7.9% decline from 2022.
  • West Pharmaceutical Services 2022 annual EBIT was $0.734B, a 2.43% decline from 2021.
  • West Pharmaceutical Services 2021 annual EBIT was $0.752B, a 84.89% increase from 2020.
West Pharmaceutical Services Annual EBIT
(Millions of US $)
2023 $676
2022 $734
2021 $752
2020 $407
2019 $297
2018 $240
2017 $226
2016 $195
2015 $129
2014 $182
2013 $162
2012 $135
2011 $110
2010 $91
2009 $98
West Pharmaceutical Services Quarterly EBIT
(Millions of US $)
2024-06-30 $126
2024-03-31 $123
2023-12-31 $161
2023-09-30 $177
2023-06-30 $183
2023-03-31 $155
2022-12-31 $130
2022-09-30 $186
2022-06-30 $228
2022-03-31 $190
2021-12-31 $184
2021-09-30 $181
2021-06-30 $211
2021-03-31 $176
2020-12-31 $116
2020-09-30 $99
2020-06-30 $104
2020-03-31 $88
2019-12-31 $78
2019-09-30 $67
2019-06-30 $81
2019-03-31 $71
2018-12-31 $66
2018-09-30 $61
2018-06-30 $60
2018-03-31 $53
2017-12-31 $60
2017-09-30 $63
2017-06-30 $42
2017-03-31 $61
2016-12-31 $53
2016-09-30 $51
2016-06-30 $61
2016-03-31 $30
2015-12-31 $45
2015-09-30 $-4
2015-06-30 $39
2015-03-31 $48
2014-12-31 $45
2014-09-30 $44
2014-06-30 $54
2014-03-31 $39
2013-12-31 $37
2013-09-30 $40
2013-06-30 $43
2013-03-31 $43
2012-12-31 $32
2012-09-30 $26
2012-06-30 $36
2012-03-31 $42
2011-12-31 $27
2011-09-30 $26
2011-06-30 $28
2011-03-31 $29
2010-12-31 $6
2010-09-30 $25
2010-06-30 $31
2010-03-31 $29
2009-12-31 $22
2009-09-30 $26
2009-06-30 $29
2009-03-31 $21
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $22.428B $2.950B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $66.939B 18.14
McKesson (MCK) United States $66.345B 18.25
Cardinal Health (CAH) United States $26.957B 14.91
Cooper (COO) United States $22.013B 31.33
Labcorp (LH) United States $19.078B 15.89
Align Technology (ALGN) United States $18.899B 36.51
Henry Schein (HSIC) United States $9.181B 16.81
Merit Medical Systems (MMSI) United States $5.746B 30.37
DENTSPLY SIRONA (XRAY) United States $5.414B 14.52
CONMED (CNMD) United States $2.343B 20.38
Patterson (PDCO) United States $1.936B 10.21
STAAR Surgical (STAA) United States $1.544B 69.76
Lifevantage (LFVN) United States $0.127B 17.48
Pro-Dex (PDEX) United States $0.086B 41.13